MedPath
TGA Approval

Cellular Therapies - T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah - Novartis Pharmaceuticals Australia Pty Ltd - Suspension - Bag (475976)

475976

Cellular Therapies - T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah - Novartis Pharmaceuticals Australia Pty Ltd - Suspension - Bag

Novartis Pharmaceuticals Australia Pty Ltd

January 16, 2025

Biological

Biological

Active

Included

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/c5ff9c88d31744a64967fab956ce2c10.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/8644b7b92362491f79d24dda6e8358fb.pdf

Active Ingredients

tisagenlecleucel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cellular Therapies - T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah - Novartis Pharmaceuticals Australia Pty Ltd - Suspension - Bag (475976) - TGA 批准文号 | MedPath